文献速递肿瘤 PET/CT核素与放射性配体治疗

核医学、分子影像与分子靶向放射性药物治疗的「火星计划」

Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy.
PubMed 文献 · J Nucl Med · 2021-01-01

核医学与分子影像学会(SNMMI)于2017年启动价值计划,其研究探索领域旨在推进诊断与治疗核医学的研发。学会相关领域及理事会负责人基于领域进展识别出5大机遇方向,并称该愿景为核医学的「火星计划」。

要点

  • SNMMI价值计划下设研究探索领域,目标是推进诊断与治疗核医学的研发。
  • 学会负责人识别出5个具有实质增长与临床影响潜力的机遇方向。
  • 该愿景被命名为核医学「火星计划」,强调目标既具远见又可实现。

核心结论

  • 核医学与分子影像学会提出核医学「火星计划」,以5大机遇方向推进诊断与治疗核医学的研发与临床转化。

研究设计与样本

  • 核医学与分子影像学会于2017年启动价值计划,其研究探索领域负责人与学会理事会识别出5大机遇方向并进行论述。

主要发现

  • 研究探索领域的努力与成果对确保核医学的光明未来及将科学转化为实践至关重要。

临床怎么用

  • 文章讨论5大增长领域,并指出其中对未来研究与发展特别重要的具体方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Society of Nuclear Medicine and Molecular Imaging created the Value Initiative in 2017 as a major component of its strategic plan to further demonstrate the value of molecular imaging and molecularly targeted radiopharmaceutical therapy to patients, physicians, payers, and funding agencies. The research and discovery domain, 1 of 5 under the Value Initiative, has a goal of advancing the research and development of diagnostic and therapeutic nuclear medicine. Research and discovery efforts and achievements are essential to ensure a bright future for NM and to translate science to practice. Given the remarkable progress in the field, leaders from the research and discovery domain and society councils identified 5 broad areas of opportunity with potential for substantive growth and clinical impact. This article discusses these 5 growth areas, identifying specific areas of particularly high importance for future study and development. As there was an understanding that goals should be both visionary yet achievable, this effort was called the Mars shot for nuclear medicine.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Wahl RL, Chareonthaitawee P, Clarke B, et al. Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy. J Nucl Med. 2021. PMID: 33334911. doi:10.2967/jnumed.120.253450

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。